Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Clinical trial NCT04202341 · RECRUITING

Trial details

NCT number: NCT04202341
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Generalized Myasthenia Gravis

Start date: 2019-12-02
Primary completion: 2029-10-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.